Obesity and diabetes: Evidence of increased perioperative risk?

Anesthesiology

Volumn 104, Issue 3, 2006, Pages 398-400

  Neligan, Patrick J ^a   Fleisher, Lee A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CYTOKINE; INSULIN; INTERLEUKIN 1; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

CONFERENCE PAPER; DIABETES CONTROL; DIABETES MELLITUS; HEART ARRHYTHMIA; HUMAN; INSULIN TREATMENT; KIDNEY FAILURE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESPIRATORY FAILURE; RISK FACTOR; RISK REDUCTION; SURGICAL PATIENT; WOUND INFECTION; ADIPOSE TISSUE; CORONARY ARTERY BYPASS GRAFT; GLUCOSE BLOOD LEVEL; METABOLISM; NOTE;

ADIPOSE TISSUE; BLOOD GLUCOSE; CORONARY ARTERY BYPASS; DIABETES COMPLICATIONS; HUMANS; OBESITY; POSTOPERATIVE COMPLICATIONS;

EID: 33645521620     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200603000-00003     Document Type: Conference Paper

References (28)

1. Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288:1723-7
2. Santry HP, Gillen DL, Lauderdale DS: Trends in bariatric surgical procedures. JAMA 2005; 294:1909-17
3. Ogunnaike BO, Jones SB, Jones DB, Provost D, Whitten CW: Anesthetic considerations for bariatric surgery. Anesthesia Analgesia 2002; 95:1793-805
4. Prabhakar G, Haan CK, Peterson ED, Coombs LP, Cruzzavala JL, Murray GF: The risks of moderate and extreme obesity for coronary artery bypass grafting outcomes: A study from the Society of Thoracic Surgeons' database. Ann Thorac Surg 2002; 74:1125-30
5. Jin R, Grunkemeier GL, Furnary AP, Handy JR Jr: Is obesity a risk factor for mortality in coronary artery bypass surgery? Circulation 2005; 111:3359-65
6. Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH: Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 2002; 40:418-23
7. Cohen Y, Raz I, Merin G, Mozes B: Comparison of factors associated with 30-day mortality after coronary artery bypass grafting in patients with versus without diabetes mellitus. Israeli Coronary Artery Bypass (ISCAB) Study Consortium. Am J Cardiol 1998; 81:7-11
8. Ouattara A, Lecomte P, Le Manach Y, Landi M, Jacqueminet S, Platonov I, Bonnet N, Riou B, Coriat P: Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. ANESTHESIOLOGY 2005; 103:687-94
9. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS: Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004; 109:1497-502
10. Pan W, Hindler K, Lee V-V, Vaughn WK, Collard CD: Obesity in diabetic patients undergoing coronary artery bypass graft surgery is associated with increased postoperative morbidity. ANESTHESIOLOGY 2006; 104:441-7
11. Karelis AD, St Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET: Metabolic and body composition factors in subgroups of obesity: What do we know? J Clin Endocrinol Metab 2004; 89:2569-75
12. Alexander CM, Landsman PB, Teutsch SM, Haffner SM: NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52:1210-4
13. Girman CJ, Rhodes T, Mercuri M, Pyorala K, Kjekshus J, Pedersen TR, Beere PA, Gotto AM, Clearfield M: The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 2004; 93:136-41
14. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288:2709-16
15. Wisse BE: The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004; 15:2792-800
16. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB: Plasma adiponectin levels and risk of myocardial infarction in men.JAMA 2004; 291: 1730-7
17. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm KR: Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004; 351:2599-610
18. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E: Elevation of tumor necrosis factor-{alpha} and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000; 101:2149-53
19. Koh KK, Han SH, Quon MJ: Inflammatory markers and the metabolic syndrome: Insights from therapeutic interventions. J Am Coll Cardiol 2005; 46:1978-85
20. Moller DE, Kaufman KD: Metabolic syndrome: A clinical and molecular perspective. Annu Rev Med 2005; 56:45-62
21. Birkmeyer NJ, Charlesworth DC, Hernandez F, Leavitt BJ, Marrin CA, Morton JR, Olmstead EM, O'Connor GT: Obesity and risk of adverse outcomes associated with coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation 1998; 97:1689-94
22. Kim J, Hammar N, Jakobsson K, Luepker RV, McGovern PG, Ivert T: Obesity and the risk of early and late mortality after coronary artery bypass graft surgery. Am Heart J 2003; 146:555-60
23. Reeves BC, Ascione R, Chamberlain MH, Angelini GD: Effect of body mass index on early outcomes in patients undergoing coronary artery bypass surgery. J Am Coll Cardiol 2003; 42:668-76
24. Van den BG: How does blood glucose control with insulin save lives in intensive care? J Clin Invest 2004; 114:1187-95
25. Jeschke MG, Klein D, Bolder U, Einspanier R: Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 2004; 145:4084-93
26. Jonassen AK, Sack MN, Mjos OD, Yellon DM: Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 2001; 89:1191-8
27. Van den BG, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-67
28. Finney SJ, Zekveld C, Elia A, Evans TW: Glucose control and mortality in critically ill patients. JAMA 2003; 290:2041-7